Related Experiment Video
Updated: Jan 18, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Clinical and Laboratory Predictors for the Development of Heart Valve Diseases in Chronic Kidney Disease: A
Hayala Machado Cavalcante Conceição1, Ana Luísa Vaz Valois1, Erick Magalhães Silva Ramos2
1Escola Bahiana de Medicina e Saúde Pública, Salvador, BA - Brasil.
Insights
In chronic kidney disease (CKD) patients, factors like age, renal replacement therapy, and inflammation significantly increase cardiac valve calcification (CVC) risk. Monitoring these can aid in prevention and treatment strategies.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Chronic kidney disease (CKD) is linked to increased valvular diseases and cardiovascular mortality.
- The specific factors driving cardiac valve calcification (CVC) in CKD patients remain unclear.
Purpose of the Study:
- To identify risk factors for valvular calcification in patients with chronic kidney disease.
Main Methods:
- A systematic review following PRISMA guidelines analyzed observational studies.
- Included studies assessed clinical and laboratory data associated with CVC in CKD patients undergoing dialysis.
- Methodological quality and risk of bias were evaluated using STROBE and Newcastle-Ottawa guidelines.
Main Results:
- Twenty studies involving 13,314 CKD patients were included.
- Key risk factors for CVC included older age (>55 years), reduced glomerular filtration rate (<53 mL/min/1.73m2), and prolonged renal replacement therapy (RRT >20 months).
- Other significant factors were hypoalbuminemia, elevated C-reactive protein (CRP), IL-6, TNF-α, parathyroid hormone, hyperphosphatemia, hypercalcemia, Ca × P product, and FGF-23, all linked to secondary hyperparathyroidism.
Conclusions:
- Age, RRT duration, chronic inflammation, and secondary hyperparathyroidism are pivotal in promoting calcium and phosphate deposition in heart valves of CKD patients.
- These factors increase susceptibility to CVC, highlighting potential targets for prevention and treatment.
Background:
Chronic kidney disease (CKD) is associated with a higher prevalence of valvular diseases and increased mortality from cardiovascular causes. Factors that influence the genesis of cardiac valve calcification (CVC) in these patients are not well-defined.
Objective:
To determine the risk factors for valvular calcification in patients with CKD.
Methods:
Systematic review based on PRISMA, which included observational studies evaluating the association of clinical and laboratory data with CVC in patients with CKD, undergoing or not hemodialysis or peritoneal dialysis. Articles were retrieved from databases (MEDLINE; SCIELO; CENTRAL; EMBASE; LILACS/BVS) and selected blindly by two authors; discrepancies were resolved by a third author. Data collection and synthesis were carried out by the main author. The assessment of methodological quality and risk of bias was based on STROBE and Newcastle-Ottawa guidelines.
Results:
A total of 783 studies were identified, of which 20 were included, encompassing 13,314 patients from 10 countries. The factors most strongly associated with CVC were age >55 years, glomerular filtration rate <53 mL/min/1.73m2, renal replacement therapy (RRT) >20 months, hypoalbuminemia, C-reactive protein (CRP), serum levels of IL-6, TNF-α, parathyroid hormone, hyperphosphatemia, hypercalcemia, Ca × P product, and FGF-23 resulting from secondary hyperparathyroidism. Both mitral and aortic valves were studied, and no differences were observed between hemodialysis and peritoneal dialysis.
Conclusion:
Age, RRT, chronic inflammation, and secondary hyperparathyroidism promote calcium and phosphate deposition in the valves, making CKD patients more susceptible to CVC) Monitoring these parameters provides opportunities for prevention and treatment.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

